Portfolio Category: Current

Ventyx Biosciences
Developing selective inhibitors of TYK2 for autoimmune diseases.
Read More


DUST Identity
Utilizes diamond crystals to enable secure identification of physical objects.
Read More


ChromaCure
Focused on the development of a first-in-class oncology therapeutic.
Read More
NorthSea Therapeutics
Focused on the development of first-in-class therapeutics for NASH and other metabolic, inflammatory and fibrotic diseases.
Read More
Vascular Therapies
Focused on the development of a drug-based solution to reduce the failure rate of AV Fistulas in dialysis patients.
Read More
Trellis Bioscience
Developer of CellSpot platform to derive therapeutic antibodies directly from the human immune system.
Read More
Svelte Medical Systems
Developer of a radial drug-eluting stent platform to simplify cardiovascular stenting procedures.
Read More
Resolve Therapeutics
Focused on the development of a biologic therapy for Lupus and Sjögren’s Syndrome.
Read More